See every side of every news story
Get Started
SubscribeLogin
World
Hockey
Government
Election
Police
Shooting
Schools
Netflix
Judge
Animals
School
Campaign
Published • loading... • Updated

Israeli ALS drug shows promise in slowing disease progression

Summary by ynetnews.com
NeuroSense Therapeutics’ Prime, a drug developed in Tel Aviv, demonstrates a 30% slowdown in disease progression in phase 2 trials

1 Articles

All
Left
1
Center
Right
ynetnews.comynetnews.com
Lean Left

Israeli ALS drug shows promise in slowing disease progression

NeuroSense Therapeutics’ Prime, a drug developed in Tel Aviv, demonstrates a 30% slowdown in disease progression in phase 2 trials

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

ynetnews.com broke the news in on Tuesday, April 15, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Israel

Israel

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal